Mirabegron for the treatment of overactive bladder: cost-effectiveness from US commercial health-plan and Medicare Advantage perspectives

2016 ◽  
Vol 19 (12) ◽  
pp. 1135-1143 ◽  
Author(s):  
Ronald C. Wielage ◽  
Sinem Perk ◽  
Noll L. Campbell ◽  
Timothy M. Klein ◽  
Linda M. Posta ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Overactive Bladder ◽  
Health Plan ◽  
Medicare Advantage

scholarly journals Collaborative care: enough of the why; what about the how?

2019 ◽  
Vol 215 (04) ◽  
pp. 573-576 ◽  
Author(s):  
Parashar Pravin Ramanuj ◽  
Harold Alan Pincus
Keyword(s):  
Quality Of Care ◽  
Cost Effectiveness ◽  
Health Plan ◽  
Collaborative Care ◽  
American Psychiatric Association ◽  
Routine Care ◽  
Healthcare Improvement

The clinical and cost-effectiveness of collaborative care for improving outcomes in people with mental and physical comorbidities is well established. However, translating these models into enduring change in routine care has proved difficult. In this editorial we outline how to shift the conversation on collaborative care from ‘what are we supposed to do?’ to ‘how we can do this’.Declaration of interestP.P.R. has received honoraria from Publicis LifeBrands and the Institute for Healthcare Improvement outside of the submitted work. H.A.P. reports personal fees from the BIND Health Plan outside of the submitted work; and is a Member of the Council on Quality of Care of the American Psychiatric Association.

scholarly journals Cost–effectiveness of overactive bladder treatments: from the US payer perspective

2019 ◽  
Vol 8 (1) ◽  
pp. 61-71 ◽  
Author(s):  
Brian Murray ◽  
Sam H Hessami ◽  
Dmitry Gultyaev ◽  
Johanna Lister ◽  
Roger Dmochowski ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Overactive Bladder ◽  
Payer Perspective ◽  
The Us

scholarly journals Cost-Effectiveness of Sacral Neuromodulation Compared to Botulinum Neurotoxin A or Continued Medical Management in Refractory Overactive Bladder

2011 ◽  
Vol 14 (2) ◽  
pp. 219-228 ◽  
Author(s):  
Salvador Arlandis ◽  
David Castro ◽  
Carlos Errando ◽  
Eldiberto Fernández ◽  
Miguel Jiménez ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Overactive Bladder ◽  
Medical Management ◽  
Botulinum Neurotoxin ◽  
Sacral Neuromodulation ◽  
Botulinum Neurotoxin A

scholarly journals Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom

2013 ◽  
Vol 16 (7) ◽  
pp. A633-A634 ◽  
Author(s):  
K. Maman ◽  
M. Neine ◽  
B. Briquet ◽  
J. Nazir ◽  
I.A.O. Odeyemi ◽  
...  
Keyword(s):  
United Kingdom ◽  
Cost Effectiveness ◽  
Overactive Bladder ◽  
The United Kingdom
Sign in / Sign up

Export Citation Format

Share Document